Results 11 to 20 of about 16,877,993 (386)

Outcome indistinguishability [PDF]

Proceedings of the 53rd Annual ACM SIGACT Symposium on Theory of Computing, 2021
Prediction algorithms assign numbers to individuals that are popularly understood as individual "probabilities" -- what is the probability of 5-year survival after cancer diagnosis? -- and which increasingly form the basis for life-altering decisions. Drawing on an understanding of computational indistinguishability developed in complexity theory and ...
Dwork, Cynthia, Kim, Michael P., Reingold, Omer, Rothblum, Guy N., Yona, Gal   +4 more
openaire   +2 more sources

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.

New England Journal of Medicine, 2023
BACKGROUND Semaglutide, a glucagon-like peptide-1 receptor agonist, has been shown to reduce the risk of adverse cardiovascular events in patients with diabetes. Whether semaglutide can reduce cardiovascular risk associated with overweight and obesity in
A. M. Lincoff, Kirstine Brown-Frandsen, H. Colhoun, J. Deanfield, S. Emerson, Sille Esbjerg, S. Hardt-Lindberg, G. Hovingh, S. Kahn, Robert F. Kushner, I. Lingvay, Tugce K Oral, Marie M Michelsen, Jorge Plutzky, Christoffer W Tornøe, D. Ryan   +15 more
semanticscholar   +1 more source

Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019

JAMA Network Open, 2020
Key Points Question What factors are associated with mental health outcomes among health care workers in China who are treating patients with coronavirus disease 2019 (COVID-19)?
Jianbo Lai, Simeng Ma, Ying Wang, Zhongxiang Cai, Jianbo Hu, N. Wei, Jiang Wu, Hui Du, Tingting Chen, Ruiting Li, Huawei Tan, Lijun Kang, L. Yao, Manli Huang, Huafen Wang, Gaohua Wang, Zhongchun Liu, Shao-hua Hu   +17 more
semanticscholar   +1 more source

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.

Journal of the American Medical Association (JAMA), 2020
Importance There is limited information describing the presenting characteristics and outcomes of US patients requiring hospitalization for coronavirus disease 2019 (COVID-19). Objective To describe the clinical characteristics and outcomes of patients
Safiya Richardson, J. Hirsch, M. Narasimhan, J. M. Crawford, T. McGinn, K. Davidson, D. Barnaby, L. Becker, J. Chelico, S. Cohen, J. Cookingham, Kevin Coppa, M. Diefenbach, Andrew J. Dominello, J. Duer-Hefele, L. Falzon, J. Gitlin, N. Hajizadeh, Tiffany G Harvin, D. Hirschwerk, Eun Ji Kim, Z. Kozel, Lyndonna M. Marrast, J. Mogavero, Gabrielle A. Osorio, M. Qiu, Theodoros P. Zanos   +26 more
semanticscholar   +1 more source

Long-term cardiovascular outcomes of COVID-19

Nature Medicine, 2022
The cardiovascular complications of acute coronavirus disease 2019 (COVID-19) are well described, but the post-acute cardiovascular manifestations of COVID-19 have not yet been comprehensively characterized.
Yan Xie, Evan Xu, Benjamin Bowe, Z. Al-Aly   +3 more
semanticscholar   +1 more source

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

JAMA cardiology, 2020
This case series study evaluates the association of underlying cardiovascular disease and myocardial injury on fatal outcomes in patients with coronavirus disease 2019 (COVID-19).
T. Guo, YongZhen Fan, Ming Chen, Xiaoyan Wu, Lin Zhang, T. He, Hairong Wang, J. Wan, Xinghuan Wang, Zhibing Lu   +9 more
semanticscholar   +1 more source

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

New England Journal of Medicine, 2020
Background Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure in patients regardless of the presence or absence of diabetes.
M. Packer, S. Anker, J. Butler, G. Filippatos, S. Pocock, P. Carson, J. Januzzi, S. Verma, H. Tsutsui, M. Brueckmann, W. Jamal, K. Kimura, J. Schnee, C. Zeller, D. Cotton, E. Bocchi, M. Böhm, D. Choi, V. Chopra, E. Chuquiure, N. Giannetti, S. Janssens, Jian Zhang, J. G. González Juanatey, S. Kaul, H. Brunner-la Rocca, B. Merkely, S. Nicholls, S. Perrone, I. Piña, P. Ponikowski, N. Sattar, M. Senni, M. Séronde, J. Špinar, I. Squire, S. Taddei, C. Wanner, F. Zannad   +38 more
semanticscholar   +1 more source

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.

New England Journal of Medicine, 2023
BACKGROUND Bempedoic acid, an ATP citrate lyase inhibitor, reduces low-density lipoprotein (LDL) cholesterol levels and is associated with a low incidence of muscle-related adverse events; its effects on cardiovascular outcomes remain uncertain ...
Nissen Se, Lincoff Am, Brennan D, Ray Kk, Mason D, Kastelein Jjp, Thompson Pd, Libby P, Cho L, Plutzky J, Bays He, Moriarty Pm, Menon V, Grobbee De, Louie Mj, Chen Cf, Li N, Bloedon L, Robinson P, Horner M, Sasiela Wj, McCluskey J, Davey D, F. P, P. P, Fedacko J, Zmuda W, Lukyanov Y, Nicholls Sj, Outcomes Investigators Nicholls Clear   +29 more
semanticscholar   +1 more source

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

New England Journal of Medicine, 2019
BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium-glucose cotransporter 2 (SGLT2), exploratory results have ...
V. Perkovic, M. Jardine, B. Neal, Severine Bompoint, H. Heerspink, D. Charytan, Robert Edwards, R. Agarwal, G. Bakris, S. Bull, C. Cannon, G. Capuano, P. Chu, D. de Zeeuw, T. Greene, A. Levin, C. Pollock, D. Wheeler, Yshai Yavin, Hong Zhang, B. Zinman, G. Meininger, B. Brenner, K. Mahaffey   +23 more
semanticscholar   +1 more source

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

New England Journal of Medicine, 2019
BACKGROUND The cardiovascular safety profile of dapagliflozin, a selective inhibitor of sodium–glucose cotransporter 2 that promotes glucosuria in patients with type 2 diabetes, is undefined. METHODS We randomly assigned patients with type 2 diabetes who
S. Wiviott, I. Raz, M. Bonaca, Ofri Mosenzon, Eri Toda Kato, A. Cahn, Michael G. Silverman, Thomas A. Zelniker, J. Kuder, S. Murphy, Deepak L. Bhatt, Lawrence A Leiter, Darren K Mcguire, J. Wilding, C. Ruff, I. Gause-Nilsson, M. Fredriksson, P. Johansson, A. Langkilde, M. Sabatine   +19 more
semanticscholar   +1 more source